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INTRODUCTION
Tumor embolization therapy was first used with
renal cell carcinomas (1) and has since been widely
employed in medicine and interventional radiology.
Recently, this method has been used for controlling
pain due to bone metastasis and management of tu-
mors which do not respond to traditional treatment.
To reduce hemorrhage during surgery, arterial em-
bolization is performed preoperatively. We evaluated
the usefulness of transcatheter arterial embolization
prior to surgical excision of musculoskeletal tumors.
MATERIALS AND METHODS
We reviewed the records of 9 patients (3 females
and 6 males) who received arterial embolization
prior to excision of musculoskeletal tumors in our
hospital from April 2009 to December 2010 (Table
1). Arterial embolization was performed selectively
using different types of micrcoils (pushable coils and
detachable coils) and gelatin sponge (GS) particles
with a coaxial technique against the feeding ves-
sels. The endpoint of embolization was disappear-
ance or sufficient reduction of tumor stain. We
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evaluated tumor location, size, histopathology, feed-
ing artery, embolic material, and blood loss during
surgery.
We statistically compared the actual amount of
intraoperative bleeding with the estimated amounts
of bleeding if arterial embolization was not per-
formed by t-test. Estimates were made after exci-
sion individually by three orthopedic surgeons with
a specialty in musculoskeletal tumors, based on pre-
operative CT, MR and angiography images (Table
2).
RESULTS
Arterial embolization was performed on the same
day or within 5 days before surgery and surgery
was performed as planned (total tumor extraction)
in all patients without serious complications. Intraop-
erative bleeding was 35-4200 mL (average : 1236
mL) (Table 3, Fig. 1-4).
The actual amount of bleeding with arterial em-
bolization was significantly (p0.01) lower than the
estimated amounts (average : 2430 mL).
Table 1 : Patient features, tumor location and size
Case No. Age Sex Location Tumor size(cm)
1 70 F Thoracic vertebra 322
2 80 M L. gluteal region 14810
3 68 M L. femoral region 547.5
4 46 M Thoracic vertebra 343
5 47 F L. shoulder 131010
6 80 M R. ilium 546
7 36 M R. retroperitoneal region 668
8 10 F L. humerus 151313
9 78 M R. femoral region 8615











1 Gelatin sponge(GS) particles 5 days 920 2067 Metastatic adenocarcinoma
2 GS particles,Microcoils 2 days 765 1367
Foreign body granuloma and hematoma
with amyloid deposition
3 GS particlesMicrocoils 1 day 35 417 MFH
4 GS particlesMicrocoils 1 day 1400 3000 Metastatic adenocarcinoma
5 GS particlesMicrocoils The same day 350 1217 Metastatic sarcoma
6 GS particlesMicrocoils The same day 4200 6000 Metastatic renal cell carcinoma
7 GS particlesMicrocoils 1 day 460 1200 MPNST
8 GS particlesMicrocoils The same day 2650 5167 Chondroblastoma
9 GS particlesMicrocoils The same day 340 1433 Liposarcoma
MFH : malignant fibrous histiocytoma
MPNST : malignant peripheral nerve sheath tumor
Table 2 : Estimated blood loss (mL)
Case No.
3 Orthopedic Surgeons
1 2 3 4 5 6 7 8 9
Dr. A 2000 1500 450 5000 650 6000 800 5000 800
Dr. B 3000 600 300 1500 1000 2000 800 500 2000
Dr. C 1200 2000 500 2500 2000 10000 2000 10000 1500
Average 2067 1367 417 3000 1217 6000 1200 5167 1433
The Journal of Medical Investigation Vol. 59 August 2012 285
Figure 1 : Case 5. A 47-year-old woman with a metastatic tumor of the left shoulder (uterine leiomyosarcoma). Tumor size was
131010 cm ; a : enhanced CT, b : MPR coronal view.
Figure 2 : Case 5. DSA of right external iliac artery ; a : pre-embolization, b : postembolization. GS particles and microcoils were used.
The actual amount of intraoperative bleeding was 350 mL and the average estimated amount of bleeding was 1217 mL.
Figure 3 : Case 9. A 78-year-old man with a liposarcoma of the right femoral region. Tumor size was 8615 cm ; a : MRI CE Fat
Sat T1WI axial & sagittal view, b : enhanced CT.
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DISCUSSION
Usefulness of embolization
One of the earliest reports of selective transcathe-
ter arterial embolization for musculoskeletal bone
tumors was in 1975 when the technique was em-
ployed to reduce perioperative blood loss. Reports
of transcatheter arterial embolization prior to exci-
sion of musculoskeletal tumors are rare but useful-
ness is reported in every case (2-7). Location, size,
and vascularity of the tumors vary widely. Operative
time and blood loss during surgery also vary widely
according to the degree of surgical intervention.
In our study, arterial embolization significantly de-
creased the amount of intraoperative blood loss com-
pared with the estimated amount of bleeding.
The interval from embolization to operation was
5 days on account of the schedule of embolization
and excision in the first case, only. Metallic embolic
coils are permanent and GS particles are temporary,
with the embolic effect lasting at least 1 week with
the latter. Generally speaking, the appropriate inter-
val would be at least one day because collateral path-
ways readily develop, we believe the usefulness is
the same if risks, such as infection, pain, and fever,
are not considered.
Advantages and indications
The advantages of transcatheter arterial emboli-
zation include minimal invasion and that hemostasis
is often possible even with difficult surgical ligation.
We consider the ideal indications for arterial emboli-
zation prior to excision of musculoskeletal tumors
are : 1. When large amounts of intraoperative bleed-
ing are expected and where bleeding would be dif-
ficult to stop. 2. Cases with a lower risk of serious
complications following embolization. 3. Cases with
hypervascular tumors of the trunk, pelvis and proxi-
mal limbs excluding the peripheral spinal region.
Embolization of bone tumors, especially vertebral
tumors
Gellad, et al. reported that in patients who under-
went adequate embolization, an average of 1,850
mL of estimated blood loss was reported. In those
who underwent inadequate or no embolization,
greater than 3,500 mL of estimated blood loss oc-
curred (8).
We performed embolization in 2 cases with metas-
tasis to the thoracic vertebrae. Angio-CT imaging
and xylocaine infusion testing was used before em-
bolization to identify the Adamkiewicz artery and
confirm that it was not involved with the tumor, thus
avoiding complications. We also used embolization
in the intercostal and lumbar arteries without com-
plications. Careful consideration of blood supply en-
abled us to perform embolization of vertebral tumors
safely and we feel this intervention should be con-
sidered in the treatment of primary or secondary
bone tumors (9).
Embolic materials
The main purpose of embolization is to achieve
thrombus formation and occlusion by administering
embolizing materials through a selective catheter
placed in an artery or vein (10). Our interventional
radiologists determined the appropriate artery and
the release site of the metallic coils after discussion
with the orthopedic surgeons.
The advantages of using metallic coils include a
stronger embolus effect than with the single use of
GS particles. Also, the position of the coils can be
Figure 4 : Case 9. DSA of the right external iliac artery ; a : pre-embolization, b : postembolization. GS particles and microcoils were
used. The actual amount of intraoperative bleeding was 340 mL and the average estimated amount of bleeding was 1433 mL.
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easily confirmed by the surgeon using intraopera-
tive fluoroscopy and palpation. The disadvantages
include the high expense and the possibility of coil
migration intraoperatively. Permanently placed coils
may also cause CT and MR imaging artifacts.
In conclusion, arterial embolization prior to resec-
tion of hypervascular musculoskeletal tumors de-
creases the amount of bleeding during the operation
and contributes to patient safety.
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